Dyslipidemia also plays a pivotal role in the activation of inflammatory pathways, increasing the production of inflammatory cytokines, mainly tumor necrosis factor alpha (TNF-α) and IL-6 [41] and inducing miRNA dysregulation [40]. Here, TNF is linked to metabolic syndrome.